Medtronic plc (MDT) Stock Analysis
A live, multi-source view of Medtronic plc (MDT): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Medtronic plc
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products.
Sector: Healthcare · Industry: Medical Devices · Ireland · 95,000 employees · medtronic.com
Key statistics · as of 2026-09-05
As of 2026-09-05, Medtronic plc (MDT) had a market capitalization of $120.46B, a trailing P/E of 23.2 (forward 14.7), a dividend yield of 3.09% and a beta of 0.57; the shares traded in a 52-week range of $73.31 – $106.33 (0.1% over the year).
- Market cap
- $120.46B
- Enterprise value
- $141.08B
- Trailing P/E
- 23.2
- Forward P/E
- 14.7
- PEG ratio
- 1.68
- Price / book
- 2.44
- EPS (trailing)
- $4.06
- EPS (forward)
- $6.40
- Dividend yield
- 3.09%
- Payout ratio
- 70.2%
- Ex-dividend date
- 2026-09-25
- 52-week range
- $73.31 – $106.33
- 52-week change
- 0.1%
- Beta
- 0.57
- Average volume
- 8.2M
- Shares outstanding
- 1.28B
- Short % of float
- 1.12%
- Profit margin
- 13.9%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-11
In RapidTradeView’s 2026-09-11 scan of the US universe, Medtronic plc (MDT) last closed at $91.62 (the last completed close before that scan).
Technicals at the scan: RSI 54 (neutral territory), price -0.4% versus its 20-day average, 20-day versus 50-day average spread +5.2%, MACD histogram -0.31.
Sentiment inputs: 96% of recent Finnhub-scored headlines read bullish; StockTwits 71% bullish; analyst consensus score 70/100.
Next scheduled company event: in 35 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 1 buy and 4 sells of MDT; corporate insiders filed 0 buys and 0 sells (5 distinct filers, latest disclosure 2026-09-01). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Kevin Hern (0B/1S), Richard McCormick (0B/1S), Tommy Tuberville (0B/1S), Julie Johnson (0B/1S), Alan Armstrong (1B/0S). Who is trading what
RapidTradeView pick record
MDT has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Medtronic plc (MDT) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell MDT.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.